LakeShore Biopharma Co., LtdLakeShore Biopharma Co., LtdLakeShore Biopharma Co., Ltd

LakeShore Biopharma Co., Ltd

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪51.52 M‬USD
‪−61.09 M‬USD
‪80.82 M‬USD
‪3.30 M‬
Beta (1Y)
0.83
Employees (FY)
758
Revenue / Employee (1Y)
‪106.62 K‬USD
Net income / Employee (1Y)
‪−80.60 K‬USD

About LakeShore Biopharma Co., Ltd


CEO
Xu Wang
Headquarters
Beijing
Founded
2020
FIGI
BBG00ZKXZ446
LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LSB is 2.96 USD — it has increased by 9.63% in the past 24 hours. Watch LakeShore Biopharma Co., Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LakeShore Biopharma Co., Ltd stocks are traded under the ticker LSB.
LSB stock has risen by 27.04% compared to the previous week, the month change is a 20.38% rise, over the last year LakeShore Biopharma Co., Ltd has showed a −40.80% decrease.
LSB reached its all-time high on Mar 15, 2023 with the price of 184.40 USD, and its all-time low was 1.88 USD and was reached on Nov 5, 2024. View more price dynamics on LSB chart.
See other stocks reaching their highest and lowest prices.
LSB stock is 34.62% volatile and has beta coefficient of 0.83. Track LakeShore Biopharma Co., Ltd stock price on the chart and check out the list of the most volatile stocks — is LakeShore Biopharma Co., Ltd there?
Today LakeShore Biopharma Co., Ltd has the market capitalization of ‪56.48 M‬, it has decreased by −0.38% over the last week.
Yes, you can track LakeShore Biopharma Co., Ltd financials in yearly and quarterly reports right on TradingView.
LakeShore Biopharma Co., Ltd is going to release the next earnings report on Apr 18, 2025. Keep track of upcoming events with our Earnings Calendar.
LSB net income for the last quarter is ‪−25.47 M‬ USD, while the quarter before that showed ‪−11.31 M‬ USD of net income which accounts for −125.13% change. Track more LakeShore Biopharma Co., Ltd financial stats to get the full picture.
No, LSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 758.00 employees. See our rating of the largest employees — is LakeShore Biopharma Co., Ltd on this list?
Like other stocks, LSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LakeShore Biopharma Co., Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LakeShore Biopharma Co., Ltd technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LakeShore Biopharma Co., Ltd stock shows the sell signal. See more of LakeShore Biopharma Co., Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.